Celularity, Inc. CELU
1.38
0.06
4.55%
as of 25 Sep
- Market cap
- $38.2M
- P/E
- 0.0×
Follow CELU
| Older periods | Mar '25 | Jun '25 | Sep '25 | Dec '25 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.80 | 1.06 | 1.34 | 1.07 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(13.60) | (47.13) | (13.11) | (5.57) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.64 | 2.01 | 2.33 | 2.64 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(16.74) | (35.27) | (14.39) | (5.29) | |
EV/FCF |
(16.22) | (33.17) | (14.05) | (5.22) | |
Quick Ratio |
0.26 | 0.17 | 0.10 | 0.13 | |
Current Ratio |
0.38 | 0.25 | 0.16 | 0.15 | |
Net Debt/EBITDA |
(4.95) | (3.03) | (3.58) | (2.06) | |
Debt/Assets |
33.48% | 36.11% | 34.98% | 44.55% | |
Debt/Equity |
(7.84) | (1.70) | (1.99) | (1.26) | |
Asset Turnover |
0.37 | 0.35 | 0.33 | 0.22 | |
Operating CF/Net income |
0.15 | 0.04 | 0.18 | 0.21 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
32.63% | 58.44% | 87.02% | 81.55% | |
Selling, General and Administrative Expense of Revenue |
124.82% | 220.26% | 176.12% | 367.06% | |
Intangible Assets out of Total Assets |
0.13 | 0.13 | 0.14 | 0.14 | |
Share Based Compensation of Revenue |
23.08% | 42.68% | 38.63% | 79.24% | |
Graham Net Nets |
(2.76) | (2.73) | (2.27) | (4.68) | |
Graham Number |
3.60 | 8.71 | 7.56 | 10.95 | |
Earnings Yield |
(142.20%) | (162.24%) | (160.87%) | (323.11%) | |
Free Cash Flow Yield |
(12.66%) | (5.74%) | (12.32%) | (47.21%) | |
Revenue per Share |
0.49 | 0.24 | 0.20 | 0.16 | |
Operating CF per Share |
(0.13) | (0.04) | (0.16) | (0.20) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.13) | (0.04) | (0.16) | (0.20) | |
Cash per Share |
0.01 | 0.04 | 0.00 | 0.24 | |
Shareholders Equity per Share |
(0.23) | (1.06) | (0.76) | (1.49) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.23) | (1.06) | (0.76) | (1.49) | |
Free Cash Flow |
(2.99) | (1.00) | (4.16) | (5.10) | |
Working Capital |
(36.61) | (51.96) | (54.72) | (68.44) | |
Net Current Asset Value |
(112.30) | (128.52) | (123.74) | (133.07) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(172.89%) | (427.55%) | (436.71%) | (595.66%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
15.40 | 12.31 | 7.74 | 9.11 | |
Average Payables |
18.15 | 19.06 | 19.99 | 24.86 | |
Average Inventory |
4.95 | 3.66 | 3.26 | 2.99 | |
Average Assets |
136.35 | 127.89 | 121.54 | 120.01 | |
Average Common Equity |
12.87 | 1.16 | (1.41) | (14.61) |
Columns are period end dates